Altimmune Inc. (NASDAQ:ALT) went down by -6.95% from its latest closing price compared to the recent 1-year high of $17.26. The company’s stock price has collected -5.58% of loss in the last five trading sessions.
Is It Worth Investing in Altimmune Inc. (NASDAQ :ALT) Right Now?
Plus, the 36-month beta value for ALT is at 0.47. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Altimmune Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $23.14, which is $11.63 above the current price. ALT currently public float of 40.86M and currently shorts hold a 10.76% ratio of that float. Today, the average trading volume of ALT was 1.44M shares.
ALT’s Market Performance
ALT stocks went down by -5.58% for the week, with a monthly drop of -5.66% and a quarterly performance of 142.32%, while its annual performance rate touched 18.05%. The volatility ratio for the week stands at 10.67% while the volatility levels for the past 30 days are set at 8.78% for Altimmune Inc. The simple moving average for the period of the last 20 days is -4.31% for ALT stocks with a simple moving average of 38.46% for the last 200 days.
Analysts’ Opinion of ALT
Many brokerage firms have already submitted their reports for ALT stocks, with Jefferies repeating the rating for ALT by listing it as a “Buy.” The predicted price for ALT in the upcoming period, according to Jefferies is $30 based on the research report published on December 29th of the previous year 2021.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see ALT reach a price target of $35. The rating they have provided for ALT stocks is “Buy” according to the report published on June 02nd, 2021.
Guggenheim gave a rating of “Buy” to ALT, setting the target price at $36 in the report published on February 11th of the previous year.
ALT Trading at 20.64% from the 50-Day Moving Average
After a stumble in the market that brought ALT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.31% of loss for the given period.
Volatility was left at 8.78%, however, over the last 30 days, the volatility rate increased by 10.67%, as shares sank -1.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +129.28% upper at present.
During the last 5 trading sessions, ALT fell by -5.58%, which changed the moving average for the period of 200-days by -4.16% in comparison to the 20-day moving average, which settled at $12.02. In addition, Altimmune Inc. saw 25.66% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at ALT starting from Roberts M Scot, who sale 10,182 shares at the price of $12.00 back on Jul 05. After this action, Roberts M Scot now owns 8,305 shares of Altimmune Inc., valued at $122,184 using the latest closing price.
Roberts M Scot, the Chief Scientific Officer of Altimmune Inc., sale 26,982 shares at $12.00 during a trade that took place back on Jul 01, which means that Roberts M Scot is holding 17,700 shares at $323,784 based on the most recent closing price.
Stock Fundamentals for ALT
Current profitability levels for the company are sitting at:
- -1937.35 for the present operating margin
- +87.50 for the gross margin
The net margin for Altimmune Inc. stands at -2201.43. Equity return is now at value -48.70, with -44.30 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 11.17.